| Dr Christopher Estiverne, MD | |
|
1602 Bayview Ave, Hillside, NJ 07205-1412 | |
| (908) 906-6054 | |
| Not Available |
| Full Name | Dr Christopher Estiverne |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 1602 Bayview Ave, Hillside, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265775746 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 285951 (Massachusetts) | Primary |
| 207R00000X | Internal Medicine | 25MA09927800 (New Jersey) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Newton-wellesley Hospital | Newton, MA | Hospital |
| Massachusetts General Hospital | Boston, MA | Hospital |
| Faulkner Hospital-brigham And Women's | Boston, MA | Hospital |
| North Shore Medical Center - | Salem, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
| Brigham And Womens Hospital Inc | 4385554732 | 53 |
News Archive
Impressive advances in our understanding of the genetic basis of disease were outlined at the 3rd ESF Functional Genomics Conference in Innsbruck, Austria.
Scientists have come up with new insight into the brain processes that cause the following optical illusion: Focus your eyes directly on the "X" in the center of the image in this short video (http://www.youtube.com/watch?v=BXnUckHbPqM&feature=player_embedded)
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).
› Verified 6 days ago
| Entity Name | Brigham & Womens Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790717650 PECOS PAC ID: 4385554732 Enrollment ID: O20040407000771 |
News Archive
Impressive advances in our understanding of the genetic basis of disease were outlined at the 3rd ESF Functional Genomics Conference in Innsbruck, Austria.
Scientists have come up with new insight into the brain processes that cause the following optical illusion: Focus your eyes directly on the "X" in the center of the image in this short video (http://www.youtube.com/watch?v=BXnUckHbPqM&feature=player_embedded)
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).
› Verified 6 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
Impressive advances in our understanding of the genetic basis of disease were outlined at the 3rd ESF Functional Genomics Conference in Innsbruck, Austria.
Scientists have come up with new insight into the brain processes that cause the following optical illusion: Focus your eyes directly on the "X" in the center of the image in this short video (http://www.youtube.com/watch?v=BXnUckHbPqM&feature=player_embedded)
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Estiverne, MD 45 Francis St, Boston, MA 02115-6105 Ph: (617) 732-6383 | Dr Christopher Estiverne, MD 1602 Bayview Ave, Hillside, NJ 07205-1412 Ph: (908) 906-6054 |
News Archive
Impressive advances in our understanding of the genetic basis of disease were outlined at the 3rd ESF Functional Genomics Conference in Innsbruck, Austria.
Scientists have come up with new insight into the brain processes that cause the following optical illusion: Focus your eyes directly on the "X" in the center of the image in this short video (http://www.youtube.com/watch?v=BXnUckHbPqM&feature=player_embedded)
Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.
Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).
› Verified 6 days ago
Dr. Edward A Somma, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 North Ave, Hillside, NJ 07205 Phone: 908-354-7070 Fax: 908-354-9300 | |
Dr. Nelson Oke Aluya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1026 Fairview Pl, Hillside, NJ 07205 Phone: 973-634-8212 |